Amanda Dell
Impact in
- Neurology top 1%
- Long-Term Effects of COVID-19
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Long-Term Effects of COVID-19 6
- Neuroinflammation and Neurodegeneration Mechanisms 2
- Vagus Nerve Stimulation Research 1
- Intracerebral and Subarachnoid Hemorrhage Research 1
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
Amanda Dell
24 papers receiving 2.7k citations
Amanda Dell's Hit Papers
Peers
Comparison fields: 5 of 116
- Neurology 1.1k
- Infectious Diseases 1.2k
- Critical Care and Intensive Care Medicine 194
- Applied Microbiology and Biotechnology 50
- Internal Medicine 63
Countries citing papers authored by Amanda Dell
This map shows the geographic impact of Amanda Dell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Dell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Dell more than expected).
Fields of papers citing papers by Amanda Dell
This network shows the impact of papers produced by Amanda Dell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Dell. The network helps show where Amanda Dell may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study Hit paper breakdown → | 2021 | 470 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 4 | Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Hit paper breakdown → | 2022 | 307 |
| 5 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 6 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 7 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 8 | 2022 | 86 | |
| 9 | 2023 | 83 | |
| 10 | 2021 | 78 | |
| 11 | Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease Hit paper breakdown → | 2024 | 65 |
| 12 | 2023 | 35 | |
| 13 | 2023 | 24 | |
| 14 | 2024 | 23 | |
| 15 | 2023 | 22 | |
| 16 | 2023 | 17 | |
| 17 | 2023 | 16 | |
| 18 | 2024 | 16 | |
| 19 | 2023 | 11 | |
| 20 | 2023 | 9 |
About Amanda Dell
Amanda Dell is a scholar working on Neurology, Infectious Diseases, Neurology, Critical Care and Intensive Care Medicine and Geriatrics and Gerontology, having authored 24 papers that have together received 2.8k indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), COVID-19 Clinical Research Studies (2 papers), Intensive Care Unit Cognitive Disorders (2 papers), Kawasaki Disease and Coronary Complications (1 paper), Vagus Nerve Stimulation Research (1 paper) and Intracerebral and Subarachnoid Hemorrhage Research (1 paper). The work is most often cited by research in Neurology (1.1k citations), Infectious Diseases (1.2k citations), Critical Care and Intensive Care Medicine (194 citations), Applied Microbiology and Biotechnology (50 citations) and Internal Medicine (63 citations). Amanda Dell has collaborated with scholars based in United Kingdom, Australia and Vietnam. Their work appears in journals such as The Lancet, The Lancet Respiratory Medicine, EClinicalMedicine, The Lancet Regional Health - Europe and International Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.